Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs Probiotics in Acne Vulgaris
NCT05629468Phase 3Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Oct 2021
- Primary completion
- Jun 2022
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acne vulgaris (3 arms), sponsored by Pak Emirates Military Hospital. Primary endpoint: Change or reduction in the Total Lesion Count at 12 weeks. Started Oct 2021; status: completed.
02
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT05629468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05629468.